Controlled release liquid pharmaceutical

Details Controlled release liquid pharmaceutical Controlled release liquid pharmaceutical

1983-10-31

1988-01-05

Brown, J. R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 54, 514 57, 514263, 514869, 514965, 514929, 514944, 514964, A61K 3700, A61K 31715

Patent

active

047177136

ABSTRACT:
A controlled release pharmaceutical composition including a solution or suspension vehicle and a pharmaceutically active agent. The composition is administered to the body in a normally liquid formulation and thereafter forms a semi-solid gel-like matrix in the environment of the stomach thereby effecting controlled release of the pharmaceutically active agent.

REFERENCES:
patent: 4002756 (1977-01-01), Higuchi et al.
patent: 4136173 (1979-01-01), Pramoda et al.
Barzegar-Jalali et al., "The Effect of Suspending Agents on the Release of Aspirin from Aqueous Suspensions In Vitro," Int. J. Pharm., vol. 2, p. 195-201, (1979).
Barzegar-Jalali et al., "The Effects of Various Suspending Agents on the Bioavailabilities of Aspirin and Salicyclic Acid in the Rabbit," Int. J. Pharm., vol. 3, pp. 133-141, (1979).
Remington's Pharmaceutical Sciences, 1980, Mack Pub. Co., pp. 1244-1248.

Affiliated with

Also associated with

Rating

Controlled release liquid pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release liquid pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release liquid pharmaceutical will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-9215